Cargando…
Interleukin-7 Reverses Lymphopenia and Improves T-Cell Function in Coronavirus Disease 2019 Patient With Inborn Error of Toll-Like Receptor 3: A Case Report
BACKGROUND: Immunotherapy treatment for coronavirus disease 2019 combined with antiviral therapy and supportive care remains under intense investigation. However, the capacity to distinguish patients who would benefit from immunosuppressive or immune stimulatory therapies remains insufficient. Here,...
Autores principales: | Mazer, Monty B., Turnbull, Isaiah R., Miles, Sydney, Blood, Teresa M., Sadler, Brooke, Hess, Annie, Botney, Mitchell D., Martin, Robert S., Bosanquet, James P., Striker, David A., Anand, Nitin S., Morre, Michel, Caldwell, Charles C., Brakenridge, Scott C., Moldawer, Lyle L., Di Paola, Jorge A., Hotchkiss, Richard S., Remy, Kenneth E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322565/ https://www.ncbi.nlm.nih.gov/pubmed/34345826 http://dx.doi.org/10.1097/CCE.0000000000000500 |
Ejemplares similares
-
Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial
por: Daix, Thomas, et al.
Publicado: (2023) -
In Vitro–Administered Dexamethasone Suppresses T Cell Function With Reversal by Interleukin-7 in Coronavirus Disease 2019
por: Mazer, Monty B., et al.
Publicado: (2021) -
Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections
por: Remy, Kenneth E., et al.
Publicado: (2020) -
Overlapping but Disparate Inflammatory and Immunosuppressive Responses to SARS-CoV-2 and Bacterial Sepsis: An Immunological Time Course Analysis
por: Loftus, Tyler J., et al.
Publicado: (2021) -
IL-7 Immunotherapy in a Nonimmunocompromised Patient With Intractable Fungal Wound Sepsis
por: Turnbull, Isaiah R, et al.
Publicado: (2021)